2023
Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic — Dharavi, Mumbai, India, 2020–2022
Gomare M, Bhide S, Deshmukh R, Kaipilyawar S, Puri V, Moonan P, Khetade D, Nyendak M, Yeldandi V, Smith J, Tobias J, Date A, Joshi R, Kumar R, Ho C. Retaining Patients with Drug-Resistant Tuberculosis on Treatment During the COVID-19 Pandemic — Dharavi, Mumbai, India, 2020–2022. MMWR Morbidity And Mortality Weekly Report 2023, 72: 304-308. PMID: 36952291, PMCID: PMC10042620, DOI: 10.15585/mmwr.mm7212a2.Peer-Reviewed Original Research
2015
Why healthcare workers are sick of TB
von Delft A, Dramowski A, Khosa C, Kotze K, Lederer P, Mosidi T, Peters JA, Smith J, van der Westhuizen HM, von Delft D, Willems B, Bates M, Craig G, Maeurer M, Marais BJ, Mwaba P, Nunes EA, Nyirenda T, Oliver M, Zumla A. Why healthcare workers are sick of TB. International Journal Of Infectious Diseases 2015, 32: 147-151. PMID: 25809771, DOI: 10.1016/j.ijid.2014.12.003.Peer-Reviewed Original ResearchConceptsDrug-resistant tuberculosisInfection control measuresHealthcare workersLife-threatening diagnosisRisk of tuberculosisOccupational tuberculosisTB diseaseTreatment optionsTB epidemicPrevalent exposureHealthcare colleaguesHealthcare resourcesUrgent interventionTuberculosisControl measuresInterventionPervasive stigmatizationFront-line workersDiseaseDiagnosisWorkers
2011
Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis.
Smith JP. Nanoparticle delivery of anti-tuberculosis chemotherapy as a potential mediator against drug-resistant tuberculosis. The Yale Journal Of Biology And Medicine 2011, 84: 361-9. PMID: 22180674, PMCID: PMC3238330.Peer-Reviewed Original ResearchConceptsDrug-resistant tuberculosisCurrent chemotherapyAnti-TB drug candidatesAnti-tuberculosis chemotherapyDuration of treatmentDrug-resistant strainsGlobal health communityPill burdenPatient adherenceTuberculosis chemotherapyChemotherapyDrug resistanceIncomplete treatmentPotential mediatorsHealth communityNanoparticle drug deliveryTuberculosisDrug candidatesDevelopment pipelineNanoparticle deliveryTreatmentDeliveryDrug delivery